Ironwood Pharmaceuticals, Inc. provided earnings guidance for the year 2022. For the year, the company expects total revenue to be in the range of $420 million to $430 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.12 USD | 0.00% | -1.22% | -29.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.02% | 1.29B | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2022